Cover Image
市場調查報告書

軟腦膜疾病 (癌性腦膜炎,軟腦膜癌病) :全球臨床實驗趨勢

Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 329071
出版日期 內容資訊 英文 69 Pages
訂單完成後即時交付
價格
Back to Top
軟腦膜疾病 (癌性腦膜炎,軟腦膜癌病) :全球臨床實驗趨勢 Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Global Clinical Trials Review, H1, 2015
出版日期: 2015年02月27日 內容資訊: 英文 69 Pages
簡介

本報告提供全球軟腦膜疾病 (癌性腦膜炎,軟腦膜癌病) 治療藥臨床實驗相關調查,提供您各地區的臨床實驗數資料,實驗階段,實驗狀況,採用主題及各類型贊助企業的臨床實驗等資料。

簡介

  • 軟腦膜疾病 (癌性腦膜炎,軟腦膜癌病)
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量

G7各國臨床實驗數量:腫瘤治療藥臨床實驗上軟腦膜疾病 (癌性腦膜炎,軟腦膜癌病) 的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

軟腦膜疾病 (癌性腦膜炎,軟腦膜癌病) 治療藥臨床實驗主要的參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Reata Pharmaceuticals, Inc.
    • SkyePharma PLC
    • Mundipharma International Limited
  • 有代表性的研究機關·醫院臨床實驗概要
    • University of Texas M. D. Anderson Cancer Center
    • Memorial Sloan Kettering Cancer Center
    • National Cancer Institute
    • Duke University
    • Northwestern University
    • Baylor College of Medicine
    • University Hospital, Bonn
    • National Cancer Center
    • National Taiwan University Hospital
    • University of Washington

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2596CTIDB

GlobalData's clinical trial report, "Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Global Clinical Trials Review, H1, 2015" provides data on the Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis)
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Countries: Proportion of Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis)
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Reata Pharmaceuticals, Inc.
      • Clinical Trial Overview of Reata Pharmaceuticals, Inc.
      • SkyePharma PLC
      • Clinical Trial Overview of SkyePharma PLC
      • Mundipharma International Limited
      • Clinical Trial Overview of Mundipharma International Limited
    • Clinical Trial Overview of Top Institutes / Government
      • University of Texas M. D. Anderson Cancer Center
      • Clinical Trial Overview of University of Texas M. D. Anderson Cancer Center
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • Duke University
      • Clinical Trial Overview of Duke University
      • Northwestern University
      • Clinical Trial Overview of Northwestern University
      • Baylor College of Medicine
      • Clinical Trial Overview of Baylor College of Medicine
      • University Hospital, Bonn
      • Clinical Trial Overview of University Hospital, Bonn
      • National Cancer Center
      • Clinical Trial Overview of National Cancer Center
      • National Taiwan University Hospital
      • Clinical Trial Overview of National Taiwan University Hospital
      • University of Washington
      • Clinical Trial Overview of University of Washington
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials by Region, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Proportion of Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Reata Pharmaceuticals, Inc., 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by SkyePharma PLC, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mundipharma International Limited, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas M. D. Anderson Cancer Center, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Bonn, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Center, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2015*

List of Figures

  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Proportion of Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top